Bogdan Batko

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Topics

Rheumatoid Arthritis

Idiopathic Pulmonary Fibrosis

Cardiovascular Risk Factors

Health Insurance

Top Venues

International journal of environmental research and public health

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk, Karolina Palej, Kornelia Chmurzyńska, Piotr Wiland, Krzysztof Batko, Bogdan Batko
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt risk. Reumatologia 61 (6) (2024)
Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international 44 (6) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Bogdan Batko, Slawomir Jeka, Piotr Wiland, Agnieszka Zielińska, Maria Stopińska-Polaszewska, Marcin Stajszczyk, Magdalena Kosydar-Piechna, Mary Jane Cadatal, Jose L Rivas
Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance. Rheumatology and therapy (2024)
Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk, Karolina Palej, Kornelia Chmurzyńska, Piotr Wiland, Krzysztof Batko, Bogdan Batko
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt risk. Reumatologia 61 (6) (2024)
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Michał Żuber, Krzysztof Tomasiewicz
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion. Reumatologia 62 (1) (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international (2024)
Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk, Karolina Palej, Kornelia Chmurzyńska, Piotr Wiland, Krzysztof Batko, Bogdan Batko
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt risk. Reumatologia 61 (6) (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international 44 (6) (2024)
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Michał Żuber, Krzysztof Tomasiewicz
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion. Reumatologia 62 (1) (2024)
Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew Michał Żuber, Bogdan Batko
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study. Polish archives of internal medicine 134 (4) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew Michał Żuber, Bogdan Batko
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study. Polish archives of internal medicine 134 (4) (2024)
Bogdan Batko, Slawomir Jeka, Piotr Wiland, Agnieszka Zielińska, Maria Stopińska-Polaszewska, Marcin Stajszczyk, Magdalena Kosydar-Piechna, Mary Jane Cadatal, Jose L Rivas
Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance. Rheumatology and therapy (2024)
Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew Michał Żuber, Bogdan Batko
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study. Polish archives of internal medicine 134 (4) (2024)
Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk, Karolina Palej, Kornelia Chmurzyńska, Piotr Wiland, Krzysztof Batko, Bogdan Batko
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt risk. Reumatologia 61 (6) (2024)
Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international 44 (6) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Marcin Stajszczyk, Izabela Obarska, Sławomir Jeka, Bogdan Batko
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database. Annals of the rheumatic diseases (2023)
Mateusz Moskal, Piotr Krawiec, Wojciech Zaręba, Izabella Świerczek, Jakub Ratusznik, Wiktor Raputa, Maciej Zieliński, Krzysztof Batko, Mikita Huk, Bogdan Batko
Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients. International journal of environmental research and public health 19 (23) (2022)
Mateusz Moskal, Piotr Krawiec, Wojciech Zaręba, Izabella Świerczek, Jakub Ratusznik, Wiktor Raputa, Maciej Zieliński, Krzysztof Batko, Mikita Huk, Bogdan Batko
Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients. International journal of environmental research and public health 19 (23) (2022)
Wojciech Jerzy Piotrowski, Magdalena Maria Martusewicz-Boros, Adam J Białas, Adam Barczyk, Bogdan Batko, Katarzyna Błasińska, Piotr W Boros, Katarzyna Gorska, Piotr Grzanka, Ewa Jassem, Dariusz Jastrzebski, Janina Kaczyńska, Otylia Kowal-Bielecka, Eugeniusz Kucharz, Jan Kuś, Barbara Kuźnar-Kamińska, Brygida Kwiatkowska, Renata Langfort, Katarzyna B Lewandowska, Barbara Mackiewicz, Sebastian Majewski, Joanna Makowska, Joanna Miłkowska-Dymanowska, Elżbieta Puścińska, Alicja Siemińska, Małgorzata Sobiecka, Renata Anna Soroka-Dąda, Małgorzata Szołkowska, Elżbieta Wiatr, Dariusz Ziora, Paweł Śliwiński
Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis. Advances in respiratory medicine 90 (5) (2022)
Mateusz Moskal, Piotr Krawiec, Wojciech Zaręba, Izabella Świerczek, Jakub Ratusznik, Wiktor Raputa, Maciej Zieliński, Krzysztof Batko, Mikita Huk, Bogdan Batko
Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients. International journal of environmental research and public health 19 (23) (2022)
Mateusz Moskal, Piotr Krawiec, Wojciech Zaręba, Izabella Świerczek, Jakub Ratusznik, Wiktor Raputa, Maciej Zieliński, Krzysztof Batko, Mikita Huk, Bogdan Batko
Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients. International journal of environmental research and public health 19 (23) (2022)
Mateusz Moskal, Piotr Krawiec, Wojciech Zaręba, Izabella Świerczek, Jakub Ratusznik, Wiktor Raputa, Maciej Zieliński, Krzysztof Batko, Mikita Huk, Bogdan Batko
Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients. International journal of environmental research and public health 19 (23) (2022)
Bogdan Batko, Eugeniusz Kucharz, Marcin Stajszczyk, Marek Brzosko, Włodzimierz Samborski, Zbigniew Żuber
Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care. Journal of clinical medicine 10 (18) (2021)
Bogdan Batko
Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis. Journal of clinical medicine 10 (24) (2021)
Bogdan Batko
Patient-Centered Care in Psoriatic Arthritis-A Perspective on Inflammation, Disease Activity, and Psychosocial Factors. Journal of clinical medicine 9 (10) (2020)
Bogdan Batko, Karol Urbański, Jerzy Świerkot, Piotr Wiland, Filip Raciborski, Mariusz Jędrzejewski, Mateusz Koziej, Marta Cześnikiewicz-Guzik, Tomasz J Guzik, Marcin Stajszczyk
Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis. Clinical rheumatology 38 (9) (2019)